Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma
about
The MST/Hippo Pathway and Cell Death: A Non-Canonical AffairGenetics and biology of pancreatic ductal adenocarcinomaEmerging role of Hippo pathway in gastric and other gastrointestinal cancersGEMMs as preclinical models for testing pancreatic cancer therapiesA Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue SarcomasTargeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer TherapyHippo Pathway in Organ Size Control, Tissue Homeostasis, and CancerMolecular Pathways: Hippo Signaling, a Critical Tumor Suppressor.Yes-Associated Protein Expression Is Correlated to the Differentiation of Prostate Adenocarcinoma.Hippo pathway mediates resistance to cytotoxic drugs.Oncoprotein YAP regulates the spindle checkpoint activation in a mitotic phosphorylation-dependent manner through up-regulation of BubR1.The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.Disease implications of the Hippo/YAP pathway.Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy.Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling.TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors.Extracellular Matrix Stiffness Regulates Osteogenic Differentiation through MAPK Activation.Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesisThe acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinomaThe emerging roles of YAP and TAZ in cancerYAP controls retinal stem cell DNA replication timing and genomic stability.Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer ProgressionCOX-2 dependent regulation of mechanotransduction in human breast cancer cellsYAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic EnhancersNF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition.Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitisRAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progressionActive YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathwayA genetic variant in large tumor suppressor kinase 2 of Hippo signaling pathway contributes to prognosis of hepatocellular carcinoma.The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapiesYAP stabilizes SMAD1 and promotes BMP2-induced neocortical astrocytic differentiationStudy of Clinical Survival and Gene Expression in a Sample of Pancreatic Ductal Adenocarcinoma by Parsimony Phylogenetic Analysis.Cell density regulates cancer metastasis via the Hippo pathway.The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.Stromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal Metaplasia.Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis.Fbxw7 Deletion Accelerates KrasG12D-Driven Pancreatic Tumorigenesis via Yap AccumulationA novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth.
P2860
Q26744308-29E0FE31-3B20-4E03-A6C2-03FAF55FAD04Q26765438-C2E8C405-4F31-49AD-AE93-AF5D23E6B4BCQ26774473-0D48C3C2-3473-4E23-A5DE-827D74B218CBQ26781848-4082C2B3-C43C-479A-8C6F-3992704B7751Q26782842-578161D7-B157-4616-8B50-227E8FA59D08Q28078129-36DF0354-07FC-423E-B375-1355232D8069Q28269498-81C59E77-9352-49A0-B3BC-98696DAE4BDCQ30369861-C751303F-6C19-48D3-ABE3-045FD836247FQ33925616-65F28413-6A37-4144-B407-61A3BDF2B7F2Q34555337-0C46CCC1-23F5-4012-B6AC-1CEFD06C81F9Q35172929-6D5E083D-98CF-4866-AB69-90C08B7582E9Q35214708-098DEBFB-DD13-4F2D-BA03-847AA78584E3Q35269102-ED00AE16-926D-42BB-838E-79C2EFA93EBEQ35484837-E5A54847-D9EC-4C3A-81A5-11529280AB5DQ35577502-2B4168BF-80CE-45EB-A289-5465B90F6A86Q35615595-2CF9EB1B-2A8F-4C84-B945-25672747F693Q35742523-1E1391DA-8164-4425-91CA-77A57818D04DQ35818801-48308E71-D49B-497A-9B58-D28C3AC3B1EDQ35954277-9B08B538-4C2B-47A3-ACC4-4CEAD5DBF8E4Q36035567-3643BABC-6F7C-4E32-AF3B-32B508772707Q36081457-93DDE4A6-D6C4-4C6C-B10F-A4A733A47940Q36117713-5AD4E5F5-FF7B-447F-89A5-D43D48A3B9CEQ36214324-2D80AB5A-52AF-4E2A-99A6-36CD1EA1D4B6Q36219267-E328A553-3D49-49AA-98EE-24B4BEB8CC47Q36273267-59547044-5577-4AD6-AD65-249F478EE125Q36280897-F550AB33-C648-4DA1-A9A3-44CCC3D4C5BFQ36398735-98F24EE4-82AF-4E58-B6CA-E904E6EABB7DQ36546520-5D78A697-20D9-4F6A-944C-FC4D3DF45B03Q36546544-2B234428-3788-412F-BCB2-A1AC0457112DQ36689006-E0A0DF1D-BB99-4327-AAB5-8A2732788DFDQ36798037-7EB870BD-6AF6-4930-A485-3A6D92E7AA86Q37058831-EFA43943-911D-43DB-8B3D-745E081F4EF5Q37120442-6421C2D2-A3C4-4036-9000-A1A1588618D5Q37141896-67E8E9CD-369C-4EE4-B4B3-C7F086D8498DQ37158424-BA321BD0-9FBC-40B9-AB7D-87BA6D2ADBF3Q37199465-F0CDEEAB-04D8-4AEE-AEDA-9758940E2C8FQ37273793-A9A16C22-253A-4A02-B959-46E91A48660BQ37306997-508D148B-8BD8-4D47-B3C8-A61220BA3EB8Q37352098-B78D8767-B524-4627-A3A1-31E7D6EC50C8Q37612660-D2236BDB-B658-430B-AF1B-8585C75C9D8A
P2860
Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Downstream of mutant KRAS, the ...... ncreatic ductal adenocarcinoma
@ast
Downstream of mutant KRAS, the ...... ncreatic ductal adenocarcinoma
@en
Downstream of mutant KRAS, the ...... ncreatic ductal adenocarcinoma
@nl
type
label
Downstream of mutant KRAS, the ...... ncreatic ductal adenocarcinoma
@ast
Downstream of mutant KRAS, the ...... ncreatic ductal adenocarcinoma
@en
Downstream of mutant KRAS, the ...... ncreatic ductal adenocarcinoma
@nl
prefLabel
Downstream of mutant KRAS, the ...... ncreatic ductal adenocarcinoma
@ast
Downstream of mutant KRAS, the ...... ncreatic ductal adenocarcinoma
@en
Downstream of mutant KRAS, the ...... ncreatic ductal adenocarcinoma
@nl
P2093
P2860
P1433
P1476
Downstream of mutant KRAS, the ...... ncreatic ductal adenocarcinoma
@en
P2093
Alias Smith
Bhaskar Kallakury
Chunling Yi
Eveline E Vietsch
Jeffrey Toretsky
Mahandranauth Chetram
Mandheer Wadhwa
Mark Manzano
Mrinmayi Joshi
P2860
P356
10.1126/SCISIGNAL.2005049
P577
2014-05-06T00:00:00Z